Research and experimental development on natural sciences and engineering
ENZYFERM AS
Revenue 2024
NOK 690,000
Operating profit
NOK −1.3m
Equity
NOK −299,000
Incorporated
2023
Share capital
NOK 1.0m
Key figures · 2024
Current ratio
1.75
Equity ratio
-18.3%
Key figures over time · 2024
| Key figures | 2024 | Trend |
|---|---|---|
| Lønnsomhet | ||
| Operating margin (%%) | -187.4% | |
| Net margin (%%) | -191.7% | |
| Return on assets (%%) | -79.1% | |
| Likviditet | ||
| Current ratio | 1.75 | |
| Working capital | 683k | |
| Soliditet | ||
| Equity ratio (%%) | -18.3% | |
| Debt-to-equity ratio | -6.46 | |
Source: Biztrac.no · Data from the Brønnøysund Register Centre and the Norwegian Tax Administration · Last updated 15.06.2026.